Cargando…
Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin
The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study th...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779489/ https://www.ncbi.nlm.nih.gov/pubmed/35050983 http://dx.doi.org/10.3390/toxins14010006 |
_version_ | 1784637589900230656 |
---|---|
author | Escrivá, Laura Agahi, Fojan Vila-Donat, Pilar Mañes, Jordi Meca, Giuseppe Manyes, Lara |
author_facet | Escrivá, Laura Agahi, Fojan Vila-Donat, Pilar Mañes, Jordi Meca, Giuseppe Manyes, Lara |
author_sort | Escrivá, Laura |
collection | PubMed |
description | The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study the bioaccessibility of aflatoxin B(1) (AFB1) and ochratoxin (OTA) in bread, as well as to evaluate the effect of milk whey (with and without lactic acid bacteria fermentation) and pumpkin on reducing mycotoxins bioaccessibility. Different bread typologies were prepared and subjected to an in vitro digestion model. Gastric and intestinal extracts were analyzed by HPLC–MS/qTOF and mycotoxins bioaccessibility was calculated. All the tested ingredients but one significantly reduced mycotoxin intestinal bioaccessibility. Pumpkin powder demonstrated to be the most effective ingredient showing significant reductions of AFB1 and OTA bioaccessibility up to 74% and 34%, respectively. Whey, fermented whey, and the combination of pumpkin-fermented whey showed intestinal bioaccessibility reductions between 57–68% for AFB1, and between 11–20% for OTA. These results pointed to pumpkin and milk whey as potential bioactive ingredients that may have promising applications in the bakery industry. |
format | Online Article Text |
id | pubmed-8779489 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87794892022-01-22 Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin Escrivá, Laura Agahi, Fojan Vila-Donat, Pilar Mañes, Jordi Meca, Giuseppe Manyes, Lara Toxins (Basel) Article The presence of mycotoxins in cereals and cereal products remains a significant issue. The use of natural ingredients such as pumpkin and whey, which contain bioactive compounds, could be a strategy to reduce the use of conventional chemical preservatives. The aim of the present work was to study the bioaccessibility of aflatoxin B(1) (AFB1) and ochratoxin (OTA) in bread, as well as to evaluate the effect of milk whey (with and without lactic acid bacteria fermentation) and pumpkin on reducing mycotoxins bioaccessibility. Different bread typologies were prepared and subjected to an in vitro digestion model. Gastric and intestinal extracts were analyzed by HPLC–MS/qTOF and mycotoxins bioaccessibility was calculated. All the tested ingredients but one significantly reduced mycotoxin intestinal bioaccessibility. Pumpkin powder demonstrated to be the most effective ingredient showing significant reductions of AFB1 and OTA bioaccessibility up to 74% and 34%, respectively. Whey, fermented whey, and the combination of pumpkin-fermented whey showed intestinal bioaccessibility reductions between 57–68% for AFB1, and between 11–20% for OTA. These results pointed to pumpkin and milk whey as potential bioactive ingredients that may have promising applications in the bakery industry. MDPI 2021-12-22 /pmc/articles/PMC8779489/ /pubmed/35050983 http://dx.doi.org/10.3390/toxins14010006 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Escrivá, Laura Agahi, Fojan Vila-Donat, Pilar Mañes, Jordi Meca, Giuseppe Manyes, Lara Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin |
title | Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin |
title_full | Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin |
title_fullStr | Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin |
title_full_unstemmed | Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin |
title_short | Bioaccessibility Study of Aflatoxin B(1) and Ochratoxin A in Bread Enriched with Fermented Milk Whey and/or Pumpkin |
title_sort | bioaccessibility study of aflatoxin b(1) and ochratoxin a in bread enriched with fermented milk whey and/or pumpkin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779489/ https://www.ncbi.nlm.nih.gov/pubmed/35050983 http://dx.doi.org/10.3390/toxins14010006 |
work_keys_str_mv | AT escrivalaura bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin AT agahifojan bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin AT viladonatpilar bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin AT manesjordi bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin AT mecagiuseppe bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin AT manyeslara bioaccessibilitystudyofaflatoxinb1andochratoxinainbreadenrichedwithfermentedmilkwheyandorpumpkin |